Drug ID: | NPD5733 |
Drug Name: | Medrogestone |
Molecular Formula: | C23H32O2 |
Canonical SMILES: | O=C1CC[C@]2(C(=C1)C(=C[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@]2(C)C(=O)C)C)C)C |
Standard InCHI: | InChI=1S/C23H32O2/c1-14-12-17-18(21(3)9-6-16(25)13-20(14)21)7-11-23(5)19(17)8-10-22(23,4)15(2)24/h12-13,17-19H,6-11H2,1-5H3/t17-,18+,19+,21-,22-,23+/m1/s1 |
Standard InCHIKey: | HCFSGRMEEXUOSS-JXEXPEPMSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | |
DrugBank | DB09124 |
ChEMBL | CHEMBL2106825 |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | 135446 |
CAS Number | 977-79-7 |
Molecular Weight | 340.24 |
ALogP | 2.0089 |
MLogP | 3.77 |
XLogP | 5.301 |
HDA | 2 |
HBD | 0 |
Rotatable Bonds | 6 |
TPSA | 34.14 |
RO5 Violation | 1 |